NEWS
Our Latest News
ARCHIMED buys Cellese, a pioneering developer of growth factors and exosome-based skincare products
ARCHIMED’s Direct Healthcare Group sees annual revenue more than double through four Buy-and-Build purchases over nine months
January
25,
2021
ARCHIMED’s BOMI Group enters new geographies and market segments through six Buy-and-Build acquisitions made over eight months
January
25,
2021
ARCHIMED buys Germany’s Zyto Group of Cancer Diagnostics companies in partnership with owners and management
January
12,
2021
ARCHIMED’s NAMSA announces key acquisition of Syntactx
January
5,
2021
368